In fact, high levels of IL-6 have been detected in the serum of patients with gastric cancer, and the increase of IL-6 levels have been considered a predictor of poor prognosis and correlated to tumor aggressiveness [1,11]. This evidence concerns the gene IL6 and neoplasm.